Search Results

Chemical synthesis of galantamine, an acetylcholinesterase inhibitor for treatment of Alzheimer’s disease

Authors: Marco-Contelles, José; Rodríguez, Carolina; García, Antonio G

Source: Expert Opinion on Therapeutic Patents, Volume 15, Number 5, 1 May 2005 , pp. 575-587(13)

Publisher: Informa Healthcare

Synthesis and Applicability of Partially Reduced 2- Benzazepines

Authors: Kouznetsov V.; Palma A.; Ewert C.

Source: Current Organic Chemistry, Volume 5, Number 5, May 2001 , pp. 519-551(36)

Publisher: Bentham Science Publishers

Enantiomeric resolution of galanthamine and related drugs used in anti-Alzheimer therapy by means of capillary zone electrophoresis employing derivatized cyclodextrin selectors

Authors: Rizzi A.; Schuh R.; Bruckner A.; Cvitkovich B.; Kremser L.; Jordis U.; Frohlich J.; Kuenburg B.; Czollner L.

Source: Journal of Chromatography B: Biomedical Sciences and Applications, Volume 730, Number 2, 9 July 1999 , pp. 167-175(9)

Publisher: Elsevier

Dynamic Diastereomeric Salt Resolution of Narwedine and its Transformation to (-)-Galanthamine

Authors: Chaplin D.A.; Johnson N.B.; Paul J.M.; Potter G.A.

Source: Tetrahedron Letters, Volume 39, Number 37, 10 September 1998 , pp. 6777-6780(4)

Publisher: Elsevier

New Kilogram-Synthesis of the Anti-Alzheimer Drug (-)-Galanthamine

Authors: Czollner L.; Frantsits W.; Kuenburg B.; Hedenig U.; Frohlich J.; Jordis U.

Source: Tetrahedron Letters, Volume 39, Number 15, 9 April 1998 , pp. 2087-2088(2)

Publisher: Elsevier

A Concise, Scaleable Synthesis of Narwedine

Authors: Chaplin D.A.; Fraser N.; Tiffin P.D.

Source: Tetrahedron Letters, Volume 38, Number 45, 10 November 1997 , pp. 7931-7932(2)

Publisher: Elsevier

Alkaloids of Galanthus elwesii

Authors: Latvala A.; Linden A.; Hesse M.; Onur M.A.; Gozler T.; Kivcak B.

Source: Phytochemistry, Volume 39, Number 5, July 1995 , pp. 1229-1240(12)

Publisher: Elsevier